News Coverage 03.10.20 Share on Twitter Share on Facebook Share on LinkedIn CRISPR-edited immune cells can survive and thrive after infusion into cancer patients Related Announcement, Our Impact PICI Network Researchers at #ASCO23 Announcement, Partner Highlight Guardant Health, PICI Launch Research Collaboration Announcement, Our Impact PICI Network Researchers at #AACR23